Clinical trial
A Randomized Multicenter Double-Blind CT to Evaluate the Efficacy and Safety of…
NCT00451867 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Terminated
Key facts
| NCT number | NCT00451867 |
|---|---|
| Title | A Randomized Multicenter Double-Blind CT to Evaluate the Efficacy and Safety of Mycophenolate Mofetil . . . |
| Official title | A Randomized Multicenter Double-Blind Clinical Trial to Evaluate the Efficacy and Safety of Mycophenolate Mofetil (CellCept) for the Treatment of Refractory Interstitial Cystitis (IC) |
| Acronym | ICCRN RCT2 |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Interstitial Cystitis, Painful Bladder Syndrome |
| Intervention type | Drug |
| Interventions | Mycophenolate Mofetil, Mycofenolate Mofetil (MMF), Placebo |
| Enrollment | 210 |
| Start date | Mar 1, 2007 |
| Primary completion | Feb 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Mar 26, 2007 |
| Last update posted | Jan 14, 2010 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: